Feb. 7th to 9th, 2024in Milan, ITALYCome and meet us at PROBIOTA in Milan, Italy.Probiota 2024, the leading Microbiome...
Blog
Make clinical data reviews more efficient with the interactive visualisation of Patient Profiles
From context to implementation of idea An important step in any clinical trial is the blind data review. This process...
![[EVENT] Biofortis will be present at FIE](https://www.biofortis.fr/wp-content/uploads/2023/10/Banner_MEET-US_FIE2023-1080x675.png)
[EVENT] Biofortis will be present at FIE
Nov. 28th to 30th, 2023in Frankfurt, GERMANYCome and meet us at Food Ingredients Europe (FIE) in Frankfurt, Germany.Fi...
![[CASE STUDY] Randomized, placebo-controlled, double-blinded study of the effect of plant extracts on glucose and lipid homeostasis in subjects with dysglycemia](https://www.biofortis.fr/wp-content/uploads/2023/05/13-400x250.png)
[CASE STUDY] Randomized, placebo-controlled, double-blinded study of the effect of plant extracts on glucose and lipid homeostasis in subjects with dysglycemia
Key informationMain study endpoints- Glycemia - Lipid and glucose profile/homeostasia - DEXAPopulation636 prediabetes patientsTested productPlant extractsInvestigations53 sites in 7 countries :...
![[CASE STUDY] Safety and suitability of an infant formula in healthy term infants](https://www.biofortis.fr/wp-content/uploads/2023/05/12-400x250.png)
[CASE STUDY] Safety and suitability of an infant formula in healthy term infants
Key informationMain study endpointsSafety: growth parameters, adverse eventsPopulation360 babiesTested productInfant formula manufactured from extensively hydrolysed proteinInvestigations21 sites...
![[CASE STUDY] Microbiome Neutral](https://www.biofortis.fr/wp-content/uploads/2023/05/Microbiome-neutral-400x250.png)
[CASE STUDY] Microbiome Neutral
Key informationObjectiveThe initial objective was to assess if the study product had an impact on microbiome composition and functionality and if there a difference in microbiome composition between...
![[CASE STUDY] Evaluation of the efficacy of a symbiotic infant formula on the incidence of gastroenterological infectious diseases during the first year of life](https://www.biofortis.fr/wp-content/uploads/2023/04/11-400x250.png)
[CASE STUDY] Evaluation of the efficacy of a symbiotic infant formula on the incidence of gastroenterological infectious diseases during the first year of life
Key informationMain study endpoints- Reduction in the incidence rate of infectious diarrhea - Modulation of intestinal microbiota - Impact on immune systemPopulation540 babiesTested productInfant...
![[ARTICLE] – How is microbiota involved in childhood mental illnesses such as ADHD and ASD?](https://www.biofortis.fr/wp-content/uploads/2023/04/Article-TDAH-TSA-Microbiota-400x250.png)
[ARTICLE] – How is microbiota involved in childhood mental illnesses such as ADHD and ASD?
There is growing evidence that the gut and the brain are linked. First observation: mental illnesses are commonly associated with gastrointestinal disorders, patients with neurological diseases...
![[EVENT] Biofortis will be present at Outsourcing In Clinical Trials Europe 2023](https://www.biofortis.fr/wp-content/uploads/2023/04/Post-SM_OCT-2023-1-400x250.png)
[EVENT] Biofortis will be present at Outsourcing In Clinical Trials Europe 2023
May 3rd and 4th, 2023in Barcelona, SpainCome and meet us at the Outsourcing In Clinical Trials (OCT) Europe 2023 in Barcelona; Spain. This event will provide participants with practical take-away...